Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial.

Priyanga RanasinghePriyadarshani GalappaththyGodwin Roger ConstantineRanil JayawardenaHasitha Dhananjaya WeeratungaSirimal PremakumaraPrasad Katulanda

Published in: Trials (2017)

Sri Lanka Clinical Trials Registry (SLCTR), identifier: SLCTR/2017/010 ( http://slctr.lk/trials/714 ). Registered on 5 April 2017; study protocol version 3.1 21 March 2017.

Keyphrases

clinical trial
study protocol
randomized controlled trial
open label
type diabetes
glycemic control
cardiovascular disease
psychometric properties
adipose tissue
cardiovascular risk factors
weight loss
double blind
essential oil